Shares of Waldencast plc (NASDAQ:WALD - Get Free Report) were up 3.9% during mid-day trading on Monday . The stock traded as high as $6.67 and last traded at $6.67. Approximately 356 shares changed hands during trading, a decline of 99% from the average daily volume of 65,186 shares. The stock had previously closed at $6.42.
Analyst Upgrades and Downgrades
Separately, Telsey Advisory Group dropped their price target on Waldencast from $12.00 to $10.00 and set an "outperform" rating on the stock in a research report on Friday, March 22nd.
Get Our Latest Stock Report on Waldencast
Waldencast Stock Performance
The stock has a 50 day moving average of $6.92 and a 200 day moving average of $8.57.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the stock. Dynamo Internacional Gestao DE Recursos LTDA. grew its stake in Waldencast by 4.6% during the 3rd quarter. Dynamo Internacional Gestao DE Recursos LTDA. now owns 15,332,933 shares of the company's stock worth $144,436,000 after buying an additional 674,600 shares during the last quarter. Barclays PLC grew its stake in shares of Waldencast by 75.3% in the third quarter. Barclays PLC now owns 7,177 shares of the company's stock worth $67,000 after purchasing an additional 3,084 shares in the last quarter. SG Americas Securities LLC bought a new position in shares of Waldencast in the third quarter worth $151,000. State Board of Administration of Florida Retirement System acquired a new position in shares of Waldencast during the third quarter valued at $97,000. Finally, Bank of New York Mellon Corp increased its holdings in shares of Waldencast by 73.6% during the third quarter. Bank of New York Mellon Corp now owns 86,409 shares of the company's stock valued at $814,000 after purchasing an additional 36,642 shares during the period. 41.97% of the stock is currently owned by institutional investors.
About Waldencast
(
Get Free Report)
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Featured Articles
Before you consider Waldencast, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waldencast wasn't on the list.
While Waldencast currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
